Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elevated Lipoprotein(a)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05135234
What this trial is testing

Developing a Physiological Understanding of High Duration Activity

Who this might be right for
Sedentary LifestyleHyperinsulinemiaGlucose Tolerance Impaired+5 more
University of Houston 60
Early research (Phase 1)Study completedNCT06229548
What this trial is testing

A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2053

Who this might be right for
Hyperlipemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 39
Large-scale testing (Phase 3)Study completedNCT02133807
What this trial is testing

Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis

Who this might be right for
AtherosclerosisCoronary DiseaseCarotid Artery Diseases
Russian Cardiology Research and Production Center 32
Not applicableWithdrawnNCT01064934
What this trial is testing

Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a)

Who this might be right for
Hyperlipoproteinemia(a)Progressive Cardiovascular Disease
Charite University, Berlin, Germany
Not applicableNot Yet RecruitingNCT07720934
What this trial is testing

A Pilot Study to Investigate Platelet Reactivity in Patients With Elevated Lipoprotein(a) and Its Response to Antiplatelet Therapy

Who this might be right for
Cardiovascular Prevention
François MACH 60
Large-scale testing (Phase 3)Looking for participantsNCT07293260
What this trial is testing

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

Who this might be right for
Cardiovascular Disease
Amgen 406
Not applicableStudy completedNCT05911724
What this trial is testing

Association Between Inflammatory Biomarkers in CVD Patients on Empagliflozin.

Who this might be right for
Stable AnginaHeart Failure
Damanhour University 180
Not applicableEnrolling By InvitationNCT07177612
What this trial is testing

Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).

Who this might be right for
Lipoprotein(a)Lipoprotein(a), Hyper-Lp(a)-Emia
Changi General Hospital 20,000
Early research (Phase 1)Study completedNCT01618916
What this trial is testing

LY3015014 in Otherwise Healthy Participants With High Low-density Lipoprotein (LDL) Cholesterol

Who this might be right for
Healthy Volunteers
Eli Lilly and Company 51
Early research (Phase 1)Looking for participantsNCT07428473
What this trial is testing

STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Elevated LDL-C and High Cholesterol
Monash University 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750341
What this trial is testing

Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 156
Testing effectiveness (Phase 2)Active Not RecruitingNCT07185776
What this trial is testing

HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Who this might be right for
Lipoprotein Disorder
Fujian Shengdi Pharmaceutical Co., Ltd. 203
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07575438
What this trial is testing

Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults

Who this might be right for
Type 2 DiabetesPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Prediabetes / Type 2 Diabetes+2 more
May Faraj, PDt, PhD 84
Not applicableLooking for participantsNCT07564752
What this trial is testing

The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Centre Hospitalier Universitaire Dijon 143
Testing effectiveness (Phase 2)Ended earlyNCT01004705
What this trial is testing

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

Who this might be right for
Elevated LDL Cholesterol
Ferrer Internacional S.A. 36
Not applicableUnknownNCT06420817
What this trial is testing

Effect of a Customised Lifestyle Medicine Strategy on Lowering Blood Lipid Levels in Indian Physicians

Who this might be right for
Lifestyle Risk ReductionCholesterol, ElevatedLDL Hyperlipoproteinemia+4 more
Jubilee Mission Medical College and Research Institute 50
Not applicableStudy completedNCT02934425
What this trial is testing

Effects of Lean Pork, High Protein Breakfast on Satiety and Metabolic Health in Pre-diabetes

Who this might be right for
Pre-diabetes
Midwest Center for Metabolic and Cardiovascular Research 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07767513
What this trial is testing

Study of Oral HRS-5346 in Adult Patients With Elevated Lipoprotein(a) and High Risk of Cardiovascular Events

Who this might be right for
Lipoprotein Disorder
Shandong Suncadia Medicine Co., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT01499420
What this trial is testing

A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients

Who this might be right for
Stable Atherothrombotic Disease
CSL Limited 45
Large-scale testing (Phase 3)Study completedNCT01953328
What this trial is testing

Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk

Who this might be right for
Hyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular Events
Amgen 409
Next Page